NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 3 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CARNEGIE MELLON UNIVERSITY | 46,970 | $87,834 | 0.12% |
| Decheng Capital Management III (Cayman), LLC | 50,000 | $92,500 | 0.03% |
| IFP Advisors, Inc | 200 | $470 | 0.00% |
External links
This page lists NEUBASE THERAPEUTICS INC's shareholders in Q2 2023. To view NEUBASE THERAPEUTICS INC's shareholder history, click here.